About: Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab
Creator	Cauda, · Cingolani, A Cipriani, · Fantoni, · Gremese, · Larosa, · Liperoti, · Montemurro, · Murri, · Pasciuto, · Pirronti, · Tummolo, ·
Source	Medline; PMC
abstract	A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks.
has issue date	2020-07-08(xsd:dateTime)
bibo:doi	10.1007/s15010-020-01476-7
bibo:pmid	32642806
has license	no-cc
sha1sum (hex)	348be78eb906edde5b1fc35ee6c84c556e77cadf
schema:url	https://doi.org/10.1007/s15010-020-01476-7
resource representing a document's title	Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab
has PubMed Central identifier	PMC7340855
has PubMed identifier	32642806
schema:publication	Infection
resource representing a document's body	covid:348be78eb906edde5b1fc35ee6c84c556e77cadf#body_text
is schema:about of	named entity 'patient' named entity 'COVID-19' named entity 'patient' named entity 'severe' named entity 'respiratory' named entity 'antagonist' named entity 'therapy' named entity 'baricitinib' named entity 'sarilumab' named entity 'dyspneic' named entity 'antivirals' named entity 'global health emergency' named entity 'janus kinase' named entity 'COVID-19' named entity 'Baricitinib' named entity 'parenchyma' named entity 'pharmacologic' named entity 'CT scan' named entity 'Treatment of Patients' named entity 'baricitinib' named entity 'receptor' named entity 'chronic obstructive pulmonary disease' named entity 'World Health Organization' named entity 'sarilumab' named entity 'ICU' named entity 'hemoglobin' named entity 'ground-glass opacities' named entity 'luminal' named entity 'respiratory rate' named entity 'dyspnea' named entity 'plasma levels' named entity 'pulmonary embolism' named entity 'Severe acute respiratory syndrome coronavirus 2' named entity 'clinical characteristics' named entity 'C-reactive protein' named entity 'remdesivir' named entity 'CT scan' named entity 'clinical practice' named entity 'IL-2' named entity 'inflammation' named entity 'COVID' named entity 'radiographic' named entity 'baricitinib' named entity 'high affinity' named entity 'anti-IL-6' named entity 'baricitinib' named entity 'lactate dehydrogenase' named entity 'baricitinib' named entity 'COVID' named entity 'COPD' named entity 'emphysema' named entity 'oxygen supplementation' named entity 'baricitinib' named entity 'canakinumab' named entity 'off-label' named entity 'baricitinib' named entity 'hematopoiesis' named entity 'plasma' named entity 'Cyclin' named entity 'sarilumab' named entity 'respiratory function' named entity '2, 3' named entity 'hypoxemia' named entity 'China' named entity 'Blood gas analysis' named entity 'IL-8' named entity 'sarilumab' named entity 'mmHg' named entity 'mmHg' named entity 'neutrophilic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software